Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Country/Region as subject
Language
Publication year range
1.
Sci Total Environ ; 454-455: 9-15, 2013 Jun 01.
Article in English | MEDLINE | ID: mdl-23538135

ABSTRACT

Five Ayurvedic medicines with mercury concentrations of 85mg/kg and higher were characterized with respect to their speciation and their bioaccessibility. X-ray absorption spectroscopy revealed that the mercury in the Ayurvedic medicines was inorganic and best matched to cinnabar, even in samples that had been hypothesized to contain mercury through plant sources only. The bioaccessibility (bioaccessible concentrations and percent bioaccessibility) was measured using two methods: a two-phase physiologically based extraction test (PBET gastric, G and gastric+intestinal phase, GI); and the fed organic estimation human simulation test (FOREhST). The percent bioaccessibility of mercury in all Ayurvedic samples was very low (<5%), corresponding to the low solubility of cinnabar, but it increased with increasing dissolved organic carbon content of the bioaccessibility solutions (PBET-G

Subject(s)
Environmental Monitoring/methods , Gastrointestinal Tract/metabolism , Materia Medica/pharmacokinetics , Medicine, Ayurvedic , Mercury Compounds/pharmacokinetics , Biological Availability , Humans , India , Materia Medica/analysis , Mercury Compounds/analysis , Plant Extracts/analysis , Plant Extracts/pharmacokinetics , Risk Assessment/methods , Spectrometry, X-Ray Emission , X-Ray Absorption Spectroscopy
2.
Sci Total Environ ; 409(21): 4545-52, 2011 Oct 01.
Article in English | MEDLINE | ID: mdl-21864885

ABSTRACT

Arsenic and lead have been found in a number of traditional Ayurvedic medicines, and the practice of Rasa Shastra (combining herbs with metals, minerals and gems), or plant ingredients that contain these elements, may be possible sources. To obtain an estimate of arsenic and lead solubility in the human gastrointestinal tract, bioaccessibility of the two elements was measured in 42 medicines, using a physiologically-based extraction test. The test consisted of a gastric phase at pH 1.8 containing organic acids, pepsin and salt, followed by an intestinal phase, at pH 7 and containing bile and pancreatin. Arsenic speciation was measured in a subset of samples that had sufficiently high arsenic concentrations for the X-ray absorption near edge structure analysis used. Bioaccessible lead was found in 76% of samples, with a large range of bioaccessibility results, but only 29% of samples had bioaccessible arsenic. Lead bioaccessibility was high (close to 100%) in a medicine (Mahayograj Guggulu) that had been compounded with bhasmas (calcined minerals), including naga (lead) bhasma. For the samples in which arsenic speciation was measured, bioaccessible arsenic was correlated with the sum of As(V)-O and As(III)-O and negatively correlated with As-S. These results suggest that the bioaccessible species in the samples had been oxidized from assumed As-S raw medicinal ingredients (realgar, As(4)S(4), added to naga (lead) bhasma and As(III)-S species in plants). Consumption at recommended doses of all medicines with bioaccessibile lead or arsenic would lead to the exceedance of at least one standard for acceptable daily intake of toxic elements.


Subject(s)
Arsenic/analysis , Arsenicals/analysis , Gastrointestinal Tract/metabolism , Lead/analysis , Medicine, Traditional , Animals , Arsenic/metabolism , Arsenicals/metabolism , Humans , Hydrogen-Ion Concentration , India , Lead/metabolism , Materia Medica/analysis , Materia Medica/metabolism , Medicine, Ayurvedic , Plant Extracts/analysis , Plant Extracts/metabolism , Risk Assessment/methods , Spectrometry, X-Ray Emission
SELECTION OF CITATIONS
SEARCH DETAIL